Research
Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study
BMJ 2017; 356 doi: https://doi.org/10.1136/bmj.j1065 (Published 17 March 2017) Cite this as: BMJ 2017;356:j1065
Data supplement
Web extra
- Data Supplement - Supplementary information: Details of the REVERSE II Study Investigators
Related articles
- Letter Published: 27 April 2017; BMJ 357 doi:10.1136/bmj.j2073
- Letter Published: 27 April 2017; BMJ 357 doi:10.1136/bmj.j2079
- Research Published: 24 July 2019; BMJ 366 doi:10.1136/bmj.l4363
- Clinical Review Published: 05 August 2020; BMJ 370 doi:10.1136/bmj.m2177
See more
- Introductory AddressProv Med Surg J October 03, 1840, s1-1 (1) 1-4; DOI: https://doi.org/10.1136/bmj.s1-1.1.1
- Report of the Meeting of the Eastern Branch of the Provincial Association at Bury St. Edmond'sProv Med Surg J October 03, 1840, s1-1 (1) 10-13; DOI: https://doi.org/10.1136/bmj.s1-1.1.10
- Mr. Warburton's Bill for the Regulation of the Medical ProfessionProv Med Surg J October 03, 1840, s1-1 (1) 13-15; DOI: https://doi.org/10.1136/bmj.s1-1.1.13
- An Atlas of Plates, illustrative of the Principles and Practice of Obstetric Medicine and Surgery, with descriptive LetterpressProv Med Surg J October 03, 1840, s1-1 (1) 4; DOI: https://doi.org/10.1136/bmj.s1-1.1.4
- A Practical Treatise on the Diseases peculiar to Women, illustrated by Cases, &cProv Med Surg J October 03, 1840, s1-1 (1) 4-5; DOI: https://doi.org/10.1136/bmj.s1-1.1.4-a
Cited by...
- Tailored anticoagulant treatment after a first venous thromboembolism: protocol of the Leiden Thrombosis Recurrence Risk Prevention (L-TRRiP) study - cohort-based randomised controlled trial
- Risk stratification for predicting recurrent venous thromboembolism after discontinuation of anticoagulation: a post hoc analysis of a French prospective multicentre study
- Evaluation of the PADIS score stratifying risk for venous thromboembolism recurrence after a first unprovoked pulmonary embolism: results from the REVERSE study
- Management of Patients With Venous Thromboembolism After the Initial Treatment Period
- Womens health in The BMJ: a data science history
- Pulmonary embolism: update on management and controversies
- 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC)
- Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis
- Six months versus two years of oral anticoagulation after a first episode of unprovoked deep-vein thrombosis. The PADIS-DVT randomized clinical trial
- Extended treatment of venous thromboembolism: a systematic review and network meta-analysis
- Venous Thromboembolism: Role of the Clinical Laboratory in Diagnosis and Management
- Fatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic review
- Anticoagulating patients with high-risk acquired thrombophilias
- Who should get long-term anticoagulant therapy for venous thromboembolism and with what?
- Who should get long-term anticoagulant therapy for venous thromboembolism and with what?
- Anticoagulating patients with high-risk acquired thrombophilias
- Breadth of complications of long-term oral anticoagulant care
- Deep vein thrombosis
- The authors respond to "Thrombophilia testing in venous thromboembolism"
- Risk factors for recurrent venous thromboembolism after unprovoked pulmonary embolism: the PADIS-PE randomised trial
- Long-term risk of recurrence after discontinuing anticoagulants for a first unprovoked venous thromboembolism: protocol for a systematic review and meta-analysis
- Stopping anticoagulation in a woman with unprovoked venous thromboembolism
- Optimizing diagnostic testing for venous thromboembolism